A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

PHASE3CompletedINTERVENTIONAL
Enrollment

1,067

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

July 31, 2010

Conditions
Type 2 Diabetes
Interventions
DRUG

Dapagliflozin

Tablets; oral; 2.5, 5.0, or 10 mg; once daily in the morning or evening for up to 102 weeks

DRUG

Dapagliflozin placebo

Tablets, oral, 0 mg, once daily in the morning or evening for up to 102 weeks

DRUG

Metformin

Trial Locations (78)

13210

Internist Associates Of Central New York, P. C., Syracuse

13413

Slocum-Dickson Medical Group, Pllc, New Hartford

14224

Southgate Medical Group, West Seneca

15216

Banksville Medical, Pc, Pittsburgh

20230

Local Institution, Aguascalientes

22320

Local Institution, Tijuana

23454

Tidewater Integrated Medical Research, Virginia Beach

29687

Southeastern Research Associates, Inc., Taylors

32205

Westside Center For Clinical Research, Jacksonville

32428

Family Care Associates, Chipley

32446

Panhandle Family Care Associates, Marianna

32701

Central Florida Clinical Trials, Altamonte Springs

34000

Local Institution, Durango

37660

Holston Medical Group, Kingsport

39159

Jackson, Danny W., Rolling Fork

43055

Newark Physician Associates, Newark

43701

Physician Research, Inc., Zanesville

44100

Local Institution, Guadalajara

44600

Local Institution, Guadalajara

44670

Local Institution, Guadalajara

44680

Local Institution, Guadalajara

45439

Providence Health Partners, Dayton

58070

Local Institution, Morelia

63017

Woodlake Research, Chesterfield

64060

Local Institution, Monterrey

64700

Local Institution, Monterrrey

70458

Louisiana Heart Center, Slidell

73008

Gilbert Medical Research, Llc, Bethany

73109

Integris Family Care Yukon, Yukon

77024

Village Family Practice, Houston

78224

Abbott Clinical Research Group, Inc., San Antonio

78229

Sam Clinical Research Center, San Antonio

80012

Aurora Family Medicine Center, P.C., Aurora

80209

Center For Internal Medicine, Denver

Denver Internal Medicine Group, Denver

80909

Expresscare Clinical Research, Colorado Springs

84010

Taylor/Wade Medical, Bountiful

84102

Optimum Clinical Research, Inc., Salt Lake City

84121

J. Lewis Research, Inc, Salt Lake City

85051

43rd Medical Associates, P.C., Phoenix

85282

Clin Res Advantage, Inc/East Valley Family Physicians, Plc, Tempe

Clinical Research Advantage, Inc, Tempe

89101

Nevada Alliance Against Diabetes, Las Vegas

90717

Torrance Clinical Research, Torrance

92117

Ritchken & First M.D.'S, San Diego

93720

Valley Research, Fresno

95032

Cherlin, Richard, Los Gatos

97070

Local Institution, Mérida

99216

William L. Gray, Md, Spokane

115093

Local Institution, Moscow

150003

Local Institution, Yaroslaval

191015

Local Institution, Saint Petersburg

195112

Local Institution, Saint Petersburg

195257

Local Institution, Saint Petersburg

214019

Local Institution, Smolensk

305035

Local Institution, Kursk

T2R 0X7

Local Institution, Calgary

V1Y 2H4

Local Institution, Kelowna

R3E 3P4

Local Institution, Winnipeg

E2A 4X7

Local Institution, Bathurst

E1G 1A7

Local Institution, Moncton

A1N 1W7

Local Institution, Mount Pearl

A1A 3R5

Local Institution, St. John's

A1E 2E2

Local Institution, St. John's

L6H 3P1

Local Institution, Oakville

N7T 4X3

Local Institution, Sarnia

L4J 8L7

Local Institution, Thornhill

M4R 2G4

Local Institution, Toronto

M9W 4L6

Local Institution, Toronto

C1A 5Y9

Local Institution, Charlottetown

J2B 7T1

Local Institution, Drummondville

J2G 8Z9

Local Institution, Granby

G2E 2X1

Local Institution, L'Ancienne-Lorette

J7J 2K8

Local Institution, Mirabel

H1S 3A9

Local Institution, Saint-Léonard

S7K 3H3

Local Institution, Saskatoon

S7K 7H9

Local Institution, Saskatoon

06726

Local Institution, Mexico, D. F.

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY